Dasania 50mg Tablet
Marketer
Lupin Ltd
Salt Composition
Dasatinib (50mg)
Overview Dasania 50mg Tablet
Leukemia treatment with Dasania 50mg tablets targets chronic myeloid leukemia. Prescribed for patients unresponsive to or intolerant of alternative leukemia therapies, this medication's 50mg dosage can be administered with or without food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose risks severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinuation should only occur under medical supervision. Common side effects include nausea, vomiting, stomach pain, and skin rash. Increased heart rate and blood pressure fluctuations (high or low) necessitate immediate medical consultation. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of ingestion. Dasania 50mg may suppress blood cell production, increasing infection risk, necessitating routine blood tests. Inform your healthcare provider about all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances occur.
Uses of Dasania 50mg Tablet
Chronic myeloid leukemia, a type of blood malignancy
Major Benefits of Dasania 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dasania 50mg Tablets can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Dasania 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Dasania 50mg Tablet:
Administer this medication precisely as prescribed by your physician, respecting both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dasania 50mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Dasania 50mg Tablet works:
Oncaspar 50mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a defective protein responsible for triggering uncontrolled cancer cell proliferation. This, in turn, restricts or decelerates the growth of cancerous tissues.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dasania 50mg Tablet hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Dasania 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Dasania 50mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Dasania 50mg Tablets may induce adverse reactions that could impair driving ability. Exercise caution while operating a vehicle if you experience side effects like dizziness or blurred vision after taking Dasania 50mg Tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Dasania 50mg tablets appear to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, a physician's consultation is recommended.
LiverSAFE IF PRESCRIBED
Dasania 50mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dasania 50mg Tablet :
Omit any missed Dasania 50mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Dasania 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine and Thiazole Derivatives |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently